Andrew R Robbins Cogent Biosciences, Inc. (COGT) insider trading activity

COGT Quotes by TradingView

Andrew R Robbins is President and CEO of Cogent Biosciences, Inc.. Currently has a direct ownership of 657,503 shares of COGT, which is worth approximately $22.1 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 367,497 shares (Common Stock) at a price of $39.45 per share, resulting in proceeds of $14,497,756. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 658K
n/a 3M change
n/a 12M change
Total Value Held $22.1 Million

Andrew R Robbins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Payment of exercise price or tax liability
$14,497,756 $39.45 p/Share
367,497 Reduced 35.85%
657,503 Common Stock
Dec 17 2025
BUY
Grant, award, or other acquisition
-
1,025,000 Added 50.0%
1,025,000 Common Stock

Also insider at

HARP
Harpoon Therapeutics, Inc. Healthcare
ARR

Andrew R Robbins

President and CEO
Cambridge, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COGT